{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:23:44Z","timestamp":1783124624582,"version":"3.54.6"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00198-022-06310-4","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T05:02:55Z","timestamp":1643173375000},"page":"1335-1346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-5303","authenticated-orcid":false,"given":"C.","family":"Beaudart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Goemaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Diez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hiligsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"6310_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-0706-y","author":"F Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","journal-title":"Arch Osteoporos"},{"key":"6310_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0136-1","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-013-0136-1","journal-title":"Arch Osteoporos"},{"key":"6310_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2005.11.024","volume":"38","author":"JY Reginster","year":"2006","unstructured":"Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:4\u20139. https:\/\/doi.org\/10.1016\/j.bone.2005.11.024","journal-title":"Bone"},{"key":"6310_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40273-020-00965-9","volume":"39","author":"N Li","year":"2021","unstructured":"Li N, Cornelissen D, Silverman S et al (2021) An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis. Pharmacoeconomics 39:181\u2013209. https:\/\/doi.org\/10.1007\/s40273-020-00965-9","journal-title":"Pharmacoeconomics"},{"key":"6310_CR5","doi-asserted-by":"publisher","DOI":"10.3310\/hta6290","author":"JA Kanis","year":"2002","unstructured":"Kanis JA, Brazier JE, Stevenson M et al (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess (Rockv). https:\/\/doi.org\/10.3310\/hta6290","journal-title":"Health Technol Assess (Rockv)"},{"key":"6310_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00223-018-00512-x","volume":"104","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Calcif Tissue Int 104:235\u2013238. https:\/\/doi.org\/10.1007\/s00223-018-00512-x","journal-title":"Calcif Tissue Int"},{"key":"6310_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/JC.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo P, Kapoor E, Asi N et al (2019) Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab 104:1623\u20131630. https:\/\/doi.org\/10.1210\/JC.2019-00192","journal-title":"J Clin Endocrinol Metab"},{"key":"6310_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3\u201344. https:\/\/doi.org\/10.1007\/s00198-018-4704-5","journal-title":"Osteoporos Int"},{"key":"6310_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26:1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"key":"6310_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.3039","volume":"32","author":"SR Cummings","year":"2017","unstructured":"Cummings SR, Cosman F, Lewiecki EM et al (2017) Goal-directed treatment for osteoporosis: a progress report from the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis. J Bone Miner Res 32:3\u201310. https:\/\/doi.org\/10.1002\/jbmr.3039","journal-title":"J Bone Miner Res"},{"key":"6310_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/acr.23279","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA et al (2017) 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 69:1095\u20131110. https:\/\/doi.org\/10.1002\/acr.23279","journal-title":"Arthritis Care Res"},{"key":"6310_CR12","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s00198-011-1545-x","volume":"22","author":"JJ Body","year":"2011","unstructured":"Body JJ, Bergmann P, Boonen S et al (2011) Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Osteoporos Int 22:2769\u20132788. https:\/\/doi.org\/10.1007\/s00198-011-1545-x","journal-title":"Osteoporos Int"},{"key":"6310_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.maturitas.2014.07.005","volume":"79","author":"R Rizzoli","year":"2014","unstructured":"Rizzoli R, Stevenson JC, Bauer JM et al (2014) The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas 79:122\u2013132. https:\/\/doi.org\/10.1016\/j.maturitas.2014.07.005","journal-title":"Maturitas"},{"key":"6310_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/HEALTHCARE5040085","volume":"5","author":"LB McMillan","year":"2017","unstructured":"McMillan LB, Zengin A, Ebeling PR, Scott D (2017) Prescribing physical activity for the prevention and treatment of osteoporosis in older adults. Healthcare 5:85. https:\/\/doi.org\/10.3390\/HEALTHCARE5040085","journal-title":"Healthcare"},{"key":"6310_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S2213-8587(21)00119-4","volume":"9","author":"R Rizzoli","year":"2021","unstructured":"Rizzoli R, Biver E, Brennan-Speranza TC (2021) Nutritional intake and bone health. Lancet Diabetes Endocrinol 9:606\u2013621. https:\/\/doi.org\/10.1016\/S2213-8587(21)00119-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6310_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-17","author":"J Lakerveld","year":"2008","unstructured":"Lakerveld J, IJzelenberg W, Van Tulder MW et al (2008) Motives for (not) participating in a lifestyle intervention trial. BMC Med Res Methodol. https:\/\/doi.org\/10.1186\/1471-2288-8-17","journal-title":"BMC Med Res Methodol"},{"key":"6310_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S1368980009990784","volume":"13","author":"K Owen","year":"2010","unstructured":"Owen K, Pettman T, Haas M et al (2010) Individual preferences for diet and exercise programmes: changes over a lifestyle intervention and their link with outcomes. Public Health Nutr 13:245\u2013252. https:\/\/doi.org\/10.1017\/S1368980009990784","journal-title":"Public Health Nutr"},{"key":"6310_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.PMEDR.2017.02.010","volume":"6","author":"DE Jarb\u00f8l","year":"2017","unstructured":"Jarb\u00f8l DE, Larsen PV, Gyrd-Hansen D et al (2017) Determinants of preferences for lifestyle changes versus medication and beliefs in ability to maintain lifestyle changes. A population-based survey. Prev Med Reports 6:66\u201373. https:\/\/doi.org\/10.1016\/J.PMEDR.2017.02.010","journal-title":"Prev Med Reports"},{"key":"6310_CR19","doi-asserted-by":"publisher","unstructured":"Gasperini B, Cherubini A, Montanari R et al (2021) How much do patients know about osteoporosis? A survey among patients referred to the dual-energy X-ray absorptiometry exam. Aging Clin Exp Res 1\u20137. https:\/\/doi.org\/10.1007\/s40520-021-01860-9","DOI":"10.1007\/s40520-021-01860-9"},{"key":"6310_CR20","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1186\/1471-2458-13-1099","volume":"13","author":"J Veldwijk","year":"2013","unstructured":"Veldwijk J, Lambooij MS, Van Gils PF et al (2013) Type 2 diabetes patients\u2019 preferences and willingness to pay for lifestyle programs: a discrete choice experiment. BMC Public Health 13:1099. https:\/\/doi.org\/10.1186\/1471-2458-13-1099","journal-title":"BMC Public Health"},{"key":"6310_CR21","doi-asserted-by":"publisher","DOI":"10.5334\/ijic.1113","author":"A M\u00fchlbacher","year":"2013","unstructured":"M\u00fchlbacher A, Bethge S (2013) Preferences of overweight and obese patients for weight loss programs: a discrete-choice experiment. Int J Integr Care. https:\/\/doi.org\/10.5334\/ijic.1113","journal-title":"Int J Integr Care"},{"key":"6310_CR22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s11764-017-0615-2","volume":"11","author":"SJ Wright","year":"2017","unstructured":"Wright SJ, Gibson D, Eden M et al (2017) What are colorectal cancer survivors\u2019 preferences for dietary advice? A best-worst discrete choice experiment. J Cancer Surviv 11:782\u2013790. https:\/\/doi.org\/10.1007\/s11764-017-0615-2","journal-title":"J Cancer Surviv"},{"key":"6310_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JFP Bridges","year":"2011","unstructured":"Bridges JFP, Hauber AB, Marshall D et al (2011) Conjoint analysis applications in health - a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Heal 14:403\u2013413. https:\/\/doi.org\/10.1016\/j.jval.2010.11.013","journal-title":"Value Heal"},{"key":"6310_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/rheumatology\/kex071","volume":"56","author":"M Hiligsmann","year":"2017","unstructured":"Hiligsmann M, Dellaert BG, Dirksen CD et al (2017) Patients\u2019 preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment. Rheumatology (United Kingdom) 56:1167\u20131176. https:\/\/doi.org\/10.1093\/rheumatology\/kex071","journal-title":"Rheumatology (United Kingdom)"},{"key":"6310_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00019053-200826080-00004","volume":"26","author":"E Lancsar","year":"2008","unstructured":"Lancsar E, Louviere J (2008) Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics 26:661\u2013677. https:\/\/doi.org\/10.2165\/00019053-200826080-00004","journal-title":"Pharmacoeconomics"},{"key":"6310_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","volume":"8","author":"EW de Bekker-Grob","year":"2015","unstructured":"de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA (2015) Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient Patient-Centered Outcomes Res 8:373\u2013384. https:\/\/doi.org\/10.1007\/s40271-015-0118-z","journal-title":"Patient Patient-Centered Outcomes Res"},{"key":"6310_CR27","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00198-019-05104-5","volume":"30","author":"M Hiligsmann","year":"2019","unstructured":"Hiligsmann M, Cornelissen D, Vrijens B et al (2019) Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal. Osteoporos Int 30:2155\u20132165. https:\/\/doi.org\/10.1007\/s00198-019-05104-5","journal-title":"Osteoporos Int"},{"key":"6310_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-01853-8","author":"E Thomas","year":"2021","unstructured":"Thomas E, Gentile A, Lakicevic N et al (2021) The effect of resistance training programs on lean body mass in postmenopausal and elderly women: a meta-analysis of observational studies. Aging Clin Exp Res. https:\/\/doi.org\/10.1007\/s40520-021-01853-8","journal-title":"Aging Clin Exp Res"},{"key":"6310_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2016.04.019","volume":"89","author":"W Kemmler","year":"2016","unstructured":"Kemmler W, von Stengel S, Kohl M (2016) Exercise frequency and bone mineral density development in exercising postmenopausal osteopenic women. Is there a critical dose of exercise for affecting bone? Results of the Erlangen Fitness and Osteoporosis Prevention Study. Bone 89:1\u20136. https:\/\/doi.org\/10.1016\/j.bone.2016.04.019","journal-title":"Bone"},{"key":"6310_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11914-017-0407-7","volume":"15","author":"W Kemmler","year":"2017","unstructured":"Kemmler W, von Stengel S, Kohl M (2017) Exercise frequency and fracture risk in older adults\u2014how often is enough? Curr Osteoporos Rep 15:564\u2013570. https:\/\/doi.org\/10.1007\/s11914-017-0407-7","journal-title":"Curr Osteoporos Rep"},{"key":"6310_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1249\/01.mss.0000678400.39345.e8","volume":"52","author":"C Ziebart","year":"2020","unstructured":"Ziebart C, MacDermid J, Szekeres M et al (2020) Barriers, facilitators, needs and goals of exercise for people with osteoporosis. Med Sci Sport Exerc 52:417\u2013417. https:\/\/doi.org\/10.1249\/01.mss.0000678400.39345.e8","journal-title":"Med Sci Sport Exerc"},{"key":"6310_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1185\/03007995.2013.766162","volume":"29","author":"R Rizzoli","year":"2013","unstructured":"Rizzoli R, Boonen S, Brandi M-L et al (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29:305\u2013313. https:\/\/doi.org\/10.1185\/03007995.2013.766162","journal-title":"Curr Med Res Opin"},{"key":"6310_CR33","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00198-018-4534-5","volume":"29","author":"R Rizzoli","year":"2018","unstructured":"Rizzoli R, Biver E, Bonjour JP et al (2018) Benefits and safety of dietary protein for bone health\u2014an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Fou. Osteoporos Int 29:1933\u20131948. https:\/\/doi.org\/10.1007\/s00198-018-4534-5","journal-title":"Osteoporos Int"},{"key":"6310_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5041-5","author":"S Bian","year":"2018","unstructured":"Bian S, Hu J, Zhang K et al (2018) Dairy product consumption and risk of hip fracture: a systematic review and meta-analysis. BMC Public Health. https:\/\/doi.org\/10.1186\/s12889-018-5041-5","journal-title":"BMC Public Health"},{"key":"6310_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40520-020-01678-x","volume":"33","author":"R Rizzoli","year":"2021","unstructured":"Rizzoli R (2021) Vitamin D supplementation: upper limit for safety revisited? Aging Clin Exp Res 33:19\u201324. https:\/\/doi.org\/10.1007\/s40520-020-01678-x","journal-title":"Aging Clin Exp Res"},{"key":"6310_CR36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","volume":"47","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J (1999) Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555\u2013567. https:\/\/doi.org\/10.1016\/S0022-3999(99)00057-4","journal-title":"J Psychosom Res"},{"key":"6310_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S1041610203008779","volume":"15","author":"LM Donini","year":"2003","unstructured":"Donini LM, Savina C, Cannella C (2003) Eating habits and appetite control in the elderly: the anorexia of aging. Int Psychogeriatrics 15:73\u201387. https:\/\/doi.org\/10.1017\/S1041610203008779","journal-title":"Int Psychogeriatrics"},{"key":"6310_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/nu8010028","author":"C Giezenaar","year":"2016","unstructured":"Giezenaar C, Chapman I, Luscombe-Marsh N et al (2016) Ageing is associated with decreases in appetite and energy intake\u2014 a meta-analysis in healthy adults. Nutrients. https:\/\/doi.org\/10.3390\/nu8010028","journal-title":"Nutrients"},{"key":"6310_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(70)91344-9","volume":"296","author":"JR Bullamore","year":"1970","unstructured":"Bullamore JR, Wilkinson R, Gallagher JC et al (1970) Effect of age on calcium absorption. Lancet 296:535\u2013537. https:\/\/doi.org\/10.1016\/S0140-6736(70)91344-9","journal-title":"Lancet"},{"key":"6310_CR40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ypmed.2012.10.001","volume":"55","author":"D Merom","year":"2012","unstructured":"Merom D, Pye V, Macniven R et al (2012) Prevalence and correlates of participation in fall prevention exercise\/physical activity by older adults. Prev Med (Baltim) 55:613\u2013617. https:\/\/doi.org\/10.1016\/j.ypmed.2012.10.001","journal-title":"Prev Med (Baltim)"},{"key":"6310_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.exger.2012.01.006","volume":"47","author":"ABM Elskamp","year":"2012","unstructured":"Elskamp ABM, Hartholt KA, Patka P et al (2012) Why older people refuse to participate in falls prevention trials: a qualitative study. Exp Gerontol 47:342\u2013345. https:\/\/doi.org\/10.1016\/j.exger.2012.01.006","journal-title":"Exp Gerontol"},{"key":"6310_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-019-0549-8","author":"LA Robles","year":"2020","unstructured":"Robles LA, Wright SJ, Hackshaw-Mcgeagh L et al (2020) Prostate cancer survivors\u2019 preferences on the delivery of diet and lifestyle advice: a pilot best-worst discrete choice experiment. Pilot Feasibility Stud. https:\/\/doi.org\/10.1186\/s40814-019-0549-8","journal-title":"Pilot Feasibility Stud"},{"key":"6310_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11914-015-0278-8","volume":"13","author":"NE Cusano","year":"2015","unstructured":"Cusano NE (2015) Skeletal effects of smoking. Curr Osteoporos Rep 13:302\u2013309. https:\/\/doi.org\/10.1007\/s11914-015-0278-8","journal-title":"Curr Osteoporos Rep"},{"key":"6310_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF02390832","volume":"68","author":"KD Ward","year":"2001","unstructured":"Ward KD, Klesges RC (2001) A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 68:259\u2013270. https:\/\/doi.org\/10.1007\/BF02390832","journal-title":"Calcif Tissue Int"},{"key":"6310_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4184190","author":"AM Al-Bashaireh","year":"2018","unstructured":"Al-Bashaireh AM, Haddad LG, Weaver M et al (2018) The effect of tobacco smoking on musculoskeletal health: a systematic review. J Environ Public Health. https:\/\/doi.org\/10.1155\/2018\/4184190","journal-title":"J Environ Public Health"},{"key":"6310_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.drugalcdep.2019.01.025","volume":"197","author":"Z Cheraghi","year":"2019","unstructured":"Cheraghi Z, Doosti-Irani A, Almasi-Hashiani A et al (2019) The effect of alcohol on osteoporosis: a systematic review and meta-analysis. Drug Alcohol Depend 197:197\u2013202. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.025","journal-title":"Drug Alcohol Depend"},{"key":"6310_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252487","volume":"16","author":"AF Turcotte","year":"2021","unstructured":"Turcotte AF, O\u2019Connor S, Morin SN et al (2021) Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS ONE 16:e0252487. https:\/\/doi.org\/10.1371\/journal.pone.0252487","journal-title":"PLoS ONE"},{"key":"6310_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005290","author":"BY Xiang","year":"2017","unstructured":"Xiang BY, Huang W, Zhou GQ et al (2017) Body mass index and the risk of low bone mass-related fractures in women compared with men: a PRISMA-compliant meta-analysis of prospective cohort studies. Medicine (United States). https:\/\/doi.org\/10.1097\/MD.0000000000005290","journal-title":"Medicine (United States)"},{"key":"6310_CR49","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","volume":"16","author":"C De Laet","year":"2005","unstructured":"De Laet C, Kanis JA, Od\u00e9n A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330\u20131338. https:\/\/doi.org\/10.1007\/s00198-005-1863-y","journal-title":"Osteoporos Int"},{"key":"6310_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1486","volume":"27","author":"CM Nielson","year":"2012","unstructured":"Nielson CM, Srikanth P, Orwoll ES (2012) Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res 27:1\u201310. https:\/\/doi.org\/10.1002\/jbmr.1486","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06310-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06310-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T10:05:29Z","timestamp":1652436329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06310-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6310"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06310-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"15 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was obtained from the Medical Ethics Committee of the Academic Hospital Maastricht and Maastricht University. Additional local ethics approval was obtained from those participating centres that required ethics approval for a DCE study, i.e., the Research Ethics Committee of Sligo University Hospital, the Southampton Joint Ethics Committee, the CEIC-Parc de Salut Mar (Committee of Ethics and Clinical Investigation) and the \u2018Commission cantonale d\u2019\u00e9thique de la recherche\u2019 (CCER) of Geneva.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"JYR has received research grant and\/or consulting fees from Servier, Novartis, Negma, Lilly, Wyeth, Amgen, GlaxoSmithKline, Roche, Merckle, Nycomed-Takeda, NPS, IBSA Genevrier, Theramex, UCB, Asahi Kasei, Endocyte, Merck Sharp and Dohme, Rottapharm, Teijin, Teva, Analis, NovoNordisk, Ebewee Pharma, Zodiac, Danone, Will Pharma, Meda, Bristol Myers Squibb, Pfizer, Organon, Therabel, Boehringer, Chiltern, Galapagos. SG has received lecture fees from Amgen and consulting fees from the advisory board of UCB. AD-P has been a speaker or advisor for Amgen, Lilly, Theramex and Active Life Scientific. RR has received consulting fees from the advisory boards of Abiogen, Amgen, Danone, Echolight, European Milk Forum, Nestl\u00e9, ObsEva, Pfizer Consumer Health, Radius Health and Theramex. BW has received speaker or consulting fees from advisory boards of Abbvie, Pfizer, Merck Sharp and Dohme, Menarini and Novartis Pharmaceuticals. The remaining authors state that they have no competing interests relevant to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}